Literature DB >> 19273610

Cholesterol metabolism: the main pathway acting downstream of cytochrome P450 oxidoreductase in skeletal development of the limb.

Katy Schmidt1, Catherine Hughes, J A Chudek, Simon R Goodyear, Richard M Aspden, Richard Talbot, Thomas E Gundersen, Rune Blomhoff, Colin Henderson, C Roland Wolf, Cheryll Tickle.   

Abstract

Cytochrome P450 oxidoreductase (POR) is the obligate electron donor for all microsomal cytochrome P450 enzymes, which catalyze the metabolism of a wide spectrum of xenobiotic and endobiotic compounds. Point mutations in POR have been found recently in patients with Antley-Bixler-like syndrome, which includes limb skeletal defects. In order to study P450 function during limb and skeletal development, we deleted POR specifically in mouse limb bud mesenchyme. Forelimbs and hind limbs in conditional knockout (CKO) mice were short with thin skeletal elements and fused joints. POR deletion occurred earlier in forelimbs than in hind limbs, leading additionally to soft tissue syndactyly and loss of wrist elements and phalanges due to changes in growth, cell death, and skeletal segmentation. Transcriptional analysis of E12.5 mouse forelimb buds demonstrated the expression of P450s involved in retinoic acid, cholesterol, and arachidonic acid metabolism. Biochemical analysis of CKO limbs confirmed retinoic acid excess. In CKO limbs, expression of genes throughout the whole cholesterol biosynthetic pathway was upregulated, and cholesterol deficiency can explain most aspects of the phenotype. Thus, cellular POR-dependent cholesterol synthesis is essential during limb and skeletal development. Modulation of P450 activity could contribute to susceptibility of the embryo and developing organs to teratogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273610      PMCID: PMC2682028          DOI: 10.1128/MCB.01638-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  98 in total

1.  Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S.

Authors:  M J McLeod
Journal:  Teratology       Date:  1980-12

2.  Immunohistochemical and microarray analyses of a mouse model for the smith-lemli-opitz syndrome.

Authors:  H Waage-Baudet; W C Dunty; D B Dehart; S Hiller; K K Sulik
Journal:  Dev Neurosci       Date:  2005       Impact factor: 2.984

3.  Preimplantation mouse blastocysts fail to express CYP genes required for estrogen biosynthesis.

Authors:  M Strömstedt; D S Keeney; M R Waterman; B C Paria; A J Conley; S K Dey
Journal:  Mol Reprod Dev       Date:  1996-04       Impact factor: 2.609

4.  Clinical phenotype of desmosterolosis.

Authors:  D R FitzPatrick; J W Keeling; M J Evans; A E Kan; J E Bell; M E Porteous; K Mills; R M Winter; P T Clayton
Journal:  Am J Med Genet       Date:  1998-01-13

5.  Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor gene.

Authors:  Hans R Waterham; Janet Koster; Petra Mooyer; Gerard van Noort Gv; Richard I Kelley; William R Wilcox; Ronald J A Wanders; Raoul C M Hennekam; Jan C Oosterwijk
Journal:  Am J Hum Genet       Date:  2003-02-28       Impact factor: 11.025

6.  Cyp26 enzymes generate the retinoic acid response pattern necessary for hindbrain development.

Authors:  Rafael E Hernandez; Aaron P Putzke; Jonathan P Myers; Lilyana Margaretha; Cecilia B Moens
Journal:  Development       Date:  2007-01       Impact factor: 6.868

7.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.

Authors:  Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

8.  The murine Cyp1a1 gene is expressed in a restricted spatial and temporal pattern during embryonic development.

Authors:  Sandra J Campbell; Colin J Henderson; Daniel C Anthony; Duncan Davidson; A John Clark; C Roland Wolf
Journal:  J Biol Chem       Date:  2004-11-29       Impact factor: 5.157

9.  Discovery of sonic hedgehog expression in postnatal growth plate chondrocytes: differential regulation of sonic and Indian hedgehog by retinoic acid.

Authors:  Licia N Y Wu; Min Lu; Brian R Genge; George Y Guo; Daotai Nie; Roy E Wuthier
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

10.  Optical projection tomography as a tool for 3D microscopy and gene expression studies.

Authors:  James Sharpe; Ulf Ahlgren; Paul Perry; Bill Hill; Allyson Ross; Jacob Hecksher-Sørensen; Richard Baldock; Duncan Davidson
Journal:  Science       Date:  2002-04-19       Impact factor: 47.728

View more
  28 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  Consequences of POR mutations and polymorphisms.

Authors:  Walter L Miller; Vishal Agrawal; Duanpen Sandee; Meng Kian Tee; Ningwu Huang; Ji Ha Choi; Kari Morrissey; Kathleen M Giacomini
Journal:  Mol Cell Endocrinol       Date:  2010-11-09       Impact factor: 4.102

3.  Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid.

Authors:  Kathrin Laue; Hans-Martin Pogoda; Philip B Daniel; Arie van Haeringen; Yasemin Alanay; Simon von Ameln; Martin Rachwalski; Tim Morgan; Mary J Gray; Martijn H Breuning; Gregory M Sawyer; Andrew J Sutherland-Smith; Peter G Nikkels; Christian Kubisch; Wilhelm Bloch; Bernd Wollnik; Matthias Hammerschmidt; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2011-10-20       Impact factor: 11.025

Review 4.  The role of vertebrate models in understanding craniosynostosis.

Authors:  Greg Holmes
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

5.  Regulation of gap junction function and Connexin 43 expression by cytochrome P450 oxidoreductase (CYPOR).

Authors:  Srikanth R Polusani; Rekha Kar; Manuel A Riquelme; Bettie Sue Masters; Satya P Panda
Journal:  Biochem Biophys Res Commun       Date:  2011-06-25       Impact factor: 3.575

Review 6.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

7.  Generation of a mouse model with a reversible hypomorphic cytochrome P450 reductase gene: utility for tissue-specific rescue of the reductase expression, and insights from a resultant mouse model with global suppression of P450 reductase expression in extrahepatic tissues.

Authors:  Yuan Wei; Xin Zhou; Cheng Fang; Lei Li; Kerri Kluetzman; Weizhu Yang; Qing-Yu Zhang; Xinxin Ding
Journal:  J Pharmacol Exp Ther       Date:  2010-04-07       Impact factor: 4.030

8.  Suppression of cytochrome P450 reductase (POR) expression in hepatoma cells replicates the hepatic lipidosis observed in hepatic POR-null mice.

Authors:  Todd D Porter; Subhashis Banerjee; Elzbieta I Stolarczyk; Ling Zou
Journal:  Drug Metab Dispos       Date:  2011-03-02       Impact factor: 3.922

9.  Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.

Authors:  Taninee Sahakitrungruang; Ningwu Huang; Meng Kian Tee; Vishal Agrawal; William E Russell; Patricia Crock; Nuala Murphy; Claude J Migeon; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

10.  Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.

Authors:  Dorota Tomalik-Scharte; Dominique Maiter; Julia Kirchheiner; Hannah E Ivison; Uwe Fuhr; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2010-09-15       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.